Abstract. One of 55 patients transplanted for sclerosing cholangitis during the cyclosporin-steroid era (March 1980-June 1986 developed intrahepatic biliary strictures in the absence of allograft rejection within the 1st year posttransplantation. Although many causes underlie biliary pathology in the postoperative period (i. e., arterial injury, ischemia, chronic rejection, cholangitis), recurrent disease remains a possibility.
Biliary tract complications after orthotopic liver transplantation (OLT) are frequent; they are mostly due to inappropriate reconstruction of the extrahepatic bile duct [1] . Recurrent disease in the allograft is common after OLT in malignant biliary tract disease but is very rare in benign biliary tract disease [2] [3] [4] [5] [6] . A patient presenting with a possible recurrent sclerosing cholangitis some months after liver transplantation is discussed.
Case report
On August 21, 1984, a 34 year-old male underwent OLT with a graft of identical blood group, type A, for end-stage primary sclerosing cholangitis (PSC) (Fig. 1) . He had been under medical management for severe ulcerative colitis since the age of 21. His past medical history revealed an uncomplicated cholecystectomy at age 27 and an appendectomy for perforative appendicitis Because of persistence of the jaundice, percutaneous biliary drainage was attempted in 1982 and 1983. Finally, a choledochojejunostomy was carried out using a transhepatic, transanastomotic U-tube, which was removed 4 months later. Repeated evaluations showed a progressive worsening of the liver disease, justifying a recommendation for treatment by OLT. The cholestasis worsened (total bilirubin, 23 mg%; alkaline phosphatases, 2020 IU). Osteoporosis was responsible for compression fractures of thoracic vertebrae 8-10 and an aseptic necrosis of the left femoral head. Gastrointestinal bleeding due to portal hypertension also occurred.
The liver grafting was uneventful: the allograft had a single arterial supply, the liver was reperfused after the completion of all four vascular anastomoses, and cold and warm ischemic times were within normal limits. The former Roux-en-Y-jejunal loop was reused for the end-to-side choledochojejunostomy. The anastomosis was carried out using a 12 French-feeding-tube stent and interrupted, absorbable 5-0 vicryl sutures. An intraoperative cholangiogram showed a normal intra-and extrahepatic biliary tree, an absence of leakage, and a patent anastomosis. The postoperative course was uneventful and the patient was discharged 20 days postsurgery with nearly normal liver function tests (LFT) [total/conjugated bilirubin (hi!. tl conj), 1.7/0.9 mg% ; alkaline phosphatase (alk.phos.) 228 IU; transaminases (SGPT/SGOT), 150125 lUll; Gamma-glutamyl-transpeptidase (G GTP), 64 IU; protime (PT), 11 s]. The rapid postoperative normalization of transaminases precluded major ischemic injury to the allograft during procurement and reimplantation.
On January 11, 1985, the patient was readmitted due to abnormal LFT (hi!. t., 1.4 mg%; alk. phos., 725 IU; SG PT ISGOT, 4001268 lUll; G GTP, 204 IU; PT, 12 s). The patient had no cholestatic symptoms. The biochemical abnormalities were attributed to an impaired cyclosporin absorption due to large amounts of diarrhea associated with a flu. Adjustment of the cyclosporin dose almost immediately normalized liver function (hi!. tl conj, 0.5/0.1 mg%; alk. phos., 341 IU; G GTP, 257 IU; SGPT/SGOT, 51128 lUll). A liver biopsy showed early changes of bile duct obstruction, such as duct dilatation, portal edema, marginal duct proliferation, and ductal ectasia. There were no remarkable signs of rejection, viral infection, or drug toxicity.
On February 20, 1985, the patient was rehospitalized due to persistent liver function abnormalities in the absence of clinical symptoms (hil.tl conj., Postop. months 145 / 82 lU l l; PT, 11.7 s). Histological examinations showed progression of the biliary obstruction and advancing portal fibrosis without evidence of graft rejection (Fig.3) . On one occasion, a Iymphogranulomatoid nodule was seen near an interlobular bile duct (Fig.4) . Portal inOammation was otherwise minimal. More than 3.5 years posttransplantation, the graft is still functioning well, which precludes a further histological examination of the organ as well as modification of the low-dose steroid -cyclosporin therapy. All posttra nspl a nt biopsies were o bta in ed accordin g to a pro tocol defining the c rit e ria o f a ll ogra ft rejection [6J a nd prepa red with hema toxy lin -eo si n stai n (H & E), tri chrome orcei n a nd rhoda nine. All sp ec ime ns we re eva lu a ted for c irrhosis, m argin a l du ctul a r p rolifera tion , gra nul o mas , porta l or septa l lymphoid nodules, the prese nce a nd loca tion of ch o les tas is, po rta l a nd/ or ce ntral vein s ube ndothe lia l in fi ltration, mo nonuclea r inn a mm a to ry cell d a mage to bil e du cts, du ctul a r lo ss, and chronic a rteri a l a nd / or venous les ions as seen in a ll o gra ft reje ction.
Discussion
C hanges in the peripheral intrahepatic bile ducts of a liver allograft m ay be the express ion of different phenomena : (a ) inadequate liver procurement, (b) in appropriate biliary tract reconstruction or (C) arterialization of the allograft, (d) (chronic) allograft rejection, (e) recurrent primary biliary tract disease, and (f) primary or recurrent viral hepatitis (1, 2, 6, 7, 9] .
Small intrahepatic ducts may be the primary ta rget of damaging immune reactions (6, 8] . Rejection c a n ca use ra pid destruction of the interlobular bile ducts associated with severe centrilobular cholestasis, margina l ductular proliferation, and nongranuloma tous cell inOammation in the portal tracts . This rapidly progressive destruction, consistent with a major clinical and chemical cholestatic picture, has been described as the " va nishing bile duct syndrome" (8] . These alterations occur in different form s related to different stages of development or to different immunosuppress ive regimens. They m ay even present as nonsuppurative destructive c holangitis, resembling the changes seen in primary bili a ry cirrhosis ( PBq (6, 10] . Only 4 of 604 grafts (0.6%) carried out durin g the period between March 129 1980 a nd June 1986 had radiological abnormalities of the intra hepatic bile ducts s imilar to those described in this case report. These abnormalities occurred within the first 12 months after transplantations carried out for a disease not primarily affecting the biliary tract. All four patients had histologically proven graft rejection prior to the development of intrahepatic bilia ry strictures (2] .
Recurrent biliary ma lignancy in the allogra ft is common after OLT ; however, recurrent, primary, benign biliary tract disease in the allograft is exceptional (6, 7] . Three cases of poss ible, late recurrence of PBe a fter OLT have been reported , although the changes in the bile duct fell short of those characteristic of PBe [5] . The liver biopsy changes in these pa tients were similar to those seen in chronic, rejection, viral hepatitis, and graft-versus-host disease. Thus, the recurrence of PBe in liver allografts has not formally been proven (5] . This was also confirmed in our recentl y reviewed seri es of 76 patients grafted during the period from March 1980 to September 1985 for advanced PBe. No instance of recurrent PBe was either clinically or histologica lly documented in the 52 surviving recipients with follow-ups of 1-6.5 years (3] .
During the same period , 55 patients were grafted for primary sclerosing cholangitis (PSC) (4] . Only 1 of 37 surviving recipients with follow-ups of 1-5 years developed chemica l and radiological abnormalities of the primary dise ase 6 months posttran splantation. The first posttransplant biopsy showed minimal or no rejection and early changes in biliary obstruction.
In the subsequent percutaneous biopsies, the changes in biliary obstruction and portal fibro sis progressed despite the absen ce of rejection. The paraductal lymphogranuloma toid nodule seen in this case was never observed in our previous tra nspl a nt biopsies (6] . Evidence of rejection or hepatitis could not be demonstrated in a ny of the allogra ft biopsies. The normalization of liver function following cyclosporin dose adju stment could be expl a ined by a mitigated rejection epi sode. However, the serial biopsy changes in the absence of allogra ft rejection are indicati ve of biliary tract pathology that would be consistent with but by no means diagnostic of recurrent sclerosing cholangitis. It is possible that the etiology of the intrahepatic bile duct strictures in this patient was due to recurrent pse, as no other cause or process capable of causing strictures could be identified. However, since there are so many other causes of biliary strictures and because the diagnosis depends on a clinicop athological correlation, we ca nnot be certain . This observation suggests that the recurrence of pse in 130 allografts, if possible, is rare. However, chronic allograft rejection must be ruled out by serial liver biopsies, as peripheral intrahepatic biliary strictures can be an unusual consequence (or some modified form) of graft rejection. In the present case report, the long-term stabilization of the patient's condition as well as of his liver function, despite identically low immunosuppression, argues against this hypothesis.
